LOGIN  |  REGISTER

Life Science Company Leadership Changes

Humana Appoints Michelle O'Hara as Chief Human Resources Officer

November 12
Last Trade: 280.06 -8.06 -2.80

LOUISVILLE, Ky. / Nov 12, 2024 / Business Wire / Leading health and well-being company Humana Inc. (NYSE: HUM) announced today that it has named Michelle O'Hara as Chief Human Resources Officer, effective January 1, 2025. O’Hara will oversee the enterprise talent strategy and people programs for Humana’s more than 63,000 employees. She brings a proven track record of transforming HR capabilities and enabling companies to effectively...Read more


HealthEquity Announces Retirement of CEO Jon Kessler; Scott Cutler Appointed Successor

November 12
Last Trade: 100.20 1.38 1.40

DRAPER, Utah, Nov. 12, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation’s largest health savings account (“HSA") custodian, today announced that after leading the company for more than 15 years, Jon Kessler, President and Chief Executive Officer, has decided to retire effective January 6, 2025. Mr. Kessler will remain a director and act a special advisor to the Company through April...Read more


Elanco Animal Health Strengthens Board of Directors with Addition of Stacey Ma

November 12
Last Trade: 14.12 0.05 0.36

Ma brings deep manufacturing and innovation expertise GREENFIELD, Ind., Nov. 12, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced the appointment of Dr. Stacey Ma to its Board of Directors, effective immediately. Dr. Ma brings extensive global leadership experience in biopharmaceutical development and manufacturing, further strengthening Elanco's expertise in these critical areas. "We are...Read more


Codexis Announces Appointment of Raymond De Vré, PhD, to Board of Directors

November 12
Last Trade: 4.02 -0.06 -1.47

REDWOOD CITY, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the appointment of Raymond De Vré, PhD, to the Company’s Board of Directors. “We are thrilled to have Raymond join the Codexis Board of Directors. He will be an invaluable resource to Codexis,” said Stephen Dilly, MBBS, PhD, Chairman and...Read more


Zoetis Appoints Jamie Brannan to Newly Created Chief Commercial Officer Role

November 11
Last Trade: 173.96 -2.86 -1.62

New Commercial Organizational Structure to Accelerate Long-Term Growth Strategy in Key Markets and Optimize Global Commercial Operations PARSIPPANY, N. J. / Nov 11, 2024 / Business Wire / Zoetis Inc. (NYSE:ZTS) today announced the appointment of Jamie Brannan to a newly created role of Chief Commercial Officer, overseeing all commercial markets across the globe for the world’s leading animal health company. In this new role, Mr....Read more


Geron Announces Appointment of Joseph Eid, M.D. as Executive Vice President, Research and Development

November 11
Last Trade: 3.97 -0.28 -6.59

FOSTER CITY, Calif. / Nov 11, 2024 / Business Wire / Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced the appointment of Joseph Eid, M.D. as Executive Vice President, Research and Development, effective today, November 11, 2024. In this role, Dr. Eid will lead our Research and Development organization comprised of medical, clinical,...Read more


Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board

November 11
Last Trade: 3.80 0.00 0.00

WELLESLEY, Mass., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM) today announced the appointment of Douglas E. Williams, Ph.D., as Climb Bio’s Chair of its Board of Directors. Dr. Williams will assume the role of Chair of the Board, succeeding Andrew Levin, who will remain on the Board as a director, while Liam Ratcliffe will step down from his position as a director. Dr. Williams has over 30 years of executive...Read more


Sunshine Health Announces the Appointment of Charlene Zein as President and CEO

November 7
Last Trade: 58.60 -1.55 -2.58

PEMBROKE PINES, Fla., Nov. 7, 2024  /PRNewswire/ -- Sunshine Health, Florida's largest managed care organization and a Centene Corporation company (NYSE: CNC), announced today Charlene Zein has been named Plan President and Chief Executive Officer, effective Nov. 3, 2024. Zein has nearly two decades of experience in the healthcare industry, including various leadership roles of increasing scope and responsibility at Sunshine...Read more


Aurinia Pharmaceuticals Appoints Craig Johnson to Board of Directors to Support Next Phase of Growth

November 7
Last Trade: 8.38 0.06 0.72

ROCKVILLE, Md. & EDMONTON, Alberta / Nov 07, 2024 / Business Wire / Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that it has appointed Craig Johnson to its Board of Directors (the Board) to support its next phase of growth. Mr. Johnson has more than 30 years of experience serving in senior financial management roles and governing companies in the biotechnology industry. He previously served as a...Read more


Collegium Pharmaceutical Appoints Vikram Karnani as Chief Executive Officer

November 7
Last Trade: 31.41 -0.75 -2.33

STOUGHTON, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that Vikram Karnani has been appointed as President and Chief Executive Officer (CEO) of Collegium and will join its Board of Directors effective November 12, 2024. Michael Heffernan, who...Read more


Sight Sciences Appoints MK Raheja as Executive Vice President, Research and Development and Brenton Taylor as Executive Vice President, Operations

November 7
Last Trade: 4.23 0.00 0.00

MENLO PARK, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, announced today the appointment of MK Raheja, Ph.D. as its Executive Vice President, Research and Development, and Brenton Taylor as its Executive Vice President,...Read more


Lifeward Announces Appointment of Robert J. Marshall to Its Board of Directors

November 7
Last Trade: 2.39 0.19 8.64

MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions in physical rehabilitation and recovery, announced the Board of Directors has approved the appointment of Robert J. Marshall Jr. as a new director effective November 2, 2024. As part of his duties as a director, Mr. Marshall will serve as...Read more


CVS Health Announces Leadership Appointments

November 6
Last Trade: 54.03 -1.51 -2.72

Prem Shah named Group President, CVS Health; Steve Nelson named President, Aetna WOONSOCKET, R.I., Nov. 6, 2024 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced Prem Shah will be Group President, and will continue to report to David Joyner, President and Chief Executive Officer. In addition, the company announced the appointment of Steve Nelson as President, Aetna, and he will also report to Joyner. Both appointments are...Read more


Nationally Recognized Healthcare Executive Dr. Jill Hoggard Green Joins Health Catalyst Board of Directors

November 6
Last Trade: 8.13 -0.11 -1.33

SALT LAKE CITY, Nov. 6, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Jill Hoggard Green, RN, BSN, MS, PhD, FAAN, former Chief Executive Officer of The Queen's Health Systems, has been appointed to serve as a member of Health Catalyst's board of directors ("Board") and a member of its...Read more


I-Mab Appoints Sean Fu, PhD, MBA, as Chief Executive Officer

November 6
Last Trade: 1.06 -0.04 -3.64

ROCKVILLE, Md., Nov. 6, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB) (the "Company"), a U.S.-based, global biotech company exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer, today announced that Sean (Xi-Yong) Fu, PhD, MBA has been appointed as the Company's permanent Chief Executive Officer ("CEO") effective November 1, 2024. Dr. Fu has served as Interim CEO since July 15, 2024....Read more


VolitionRx Appoints Timothy I. Still as Chairman

November 6
Last Trade: 0.75 0.05 7.83

HENDERSON, Nev., Nov. 6, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has appointed Timothy Still as Chairman of its board of directors, effective November 06, 2024. Mr. Still is currently Chairman and CEO of TSTILL Enterprises LLC, and an Operating Partner with REVIVAL Healthcare. An accomplished executive with a career spanning over 35 years in medical...Read more


SOPHiA GENETICS Promotes Ross Muken to President and Appoints George Cardoza as Chief Financial Officer

November 5
Last Trade: 3.99 0.47 13.35

BOSTON and ROLLE, Switzerland, Nov. 5, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine, today announced that Ross Muken, previously Chief Financial Officer ("CFO") and Chief Operating Officer ("COO"), has been promoted to company President, effective November 5, 2024. George Cardoza has been appointed as the company's new CFO. In the newly created role of...Read more


Utah Medical Products Appoints Director and Increases Quarterly Dividend

November 5
Last Trade: 68.35 0.44 0.65

SALT LAKE CITY, UT / ACCESSWIRE / November 5, 2024 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors has appointed Carrie Leigh to its Board of Directors. Ms. Leigh, who was employed in direct sales positions for UTMD from 2004 to 2016, graduated with a B.S. in Communications from Santa Clara University and an MBA from the Northwestern University Kellogg School of Management. As she served in her last...Read more


Atossa Therapeutics Appoints Claudia Lopez, DVM, MSc, as Vice President, Clinical Product Development

November 5
Last Trade: 1.50 0.00 0.00

SEATTLE, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), today announced the appointment of Claudia Lopez, DVM, MSc, as its new Vice President, Clinical Product Development. Dr. Lopez brings more than two decades of clinical development and strategic expertise to Atossa, including leadership roles in global clinical programs across immunology, oncology, and metabolic disease. Atossa...Read more


Legend Biotech Appoints Alan Bash as President of CARVYKTI®

November 4
Last Trade: 40.18 0.15 0.37

SOMERSET, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced the appointment of Alan Bash as the Company’s President of CARVYKTI®. In this newly created role, Mr. Bash will be responsible for managing the continued growth of CARVYKTI®, overseeing Legend Biotech’s commercial, technical operations, and quality functions of the...Read more


Azenta Announces the Addition of Three New Independent Directors Effective Immediately and New Initiative to Drive Value

November 4
Last Trade: 45.99 1.21 2.70

William L. Cornog, Quentin Koffey and Alan J. Malus Add Deep Industry Expertise and Track Records of Shareholder Value Creation to the Board Establishes Value Creation Committee of the Board Comprised of New Directors, CEO John Marotta, and Current Director Martin Madaus Reaffirms Full-Year 2024 Financial Guidance BURLINGTON, Mass., Nov. 4, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) ("Azenta" or "the Company"),...Read more


Integra LifeSciences Announces Appointment of Mojdeh Poul as President and Chief Executive Officer

November 4
Last Trade: 24.81 0.03 0.12

PRINCETON, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced that its board of directors has appointed Mojdeh Poul as the new president and chief executive officer, effective January 6, 2025. Ms. Poul will also join the Integra board when she assumes the role. She will succeed Jan De Witte, who will remain president and CEO until...Read more


Aveanna Healthcare Announces Appointment of New Director

November 4
Last Trade: 5.80 -0.03 -0.51

ATLANTA, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Brent Layton to serve as a Class III director of the Board of Directors of Aveanna Healthcare Holdings Inc., and additionally as a member of the Audit Committee of the Board, effective November...Read more


InnovAge Appoints Michael Scarbrough as New President and Chief Operating Officer and Maria Lozzano as President, Pharmacy Services

November 4
Last Trade: 5.74 -0.26 -4.33

DENVER, Nov. 04, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), appoints Michael Scarbrough as its new President and Chief Operating Officer and Maria Lozzano as President, Pharmacy Services, effective November 4th. Mr. Scarbrough joins...Read more


Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations

November 4
Last Trade: 7.02 0.28 4.15

Brings Strong Background in Pharmaceutical Manufacturing Operations and Finance to Help Drive Performance and Productivity Jackie Klecker Named Executive Vice President, Quality and Development Services to Focus on Sustaining Company’s Strong Regulatory and Compliance Track Record Personnel Moves Bifurcate Operations and Quality Functions to Align with Company’s Growth Strategy and Reflect Natural Evolution of Business CHASKA,...Read more


Heron Therapeutics Announces Appointment of Michael Kaseta to Board of Directors

November 4
Last Trade: 1.28 -0.47 -26.86

SAN DIEGO, Nov. 4, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, announced today the appointment of Michael Kaseta to its Board of Directors. Mr. Kaseta has an extensive background spanning corporate finance, business strategy, and the commercialization of biopharma products in large pharmaceutical companies and small biotech companies. Mr. Kaseta currently serves as the Chief...Read more


Clearside Biomedical Appoints Tony Gibney as New Chair of the Board of Directors

November 4
Last Trade: 1.11 -0.03 -2.63

ALPHARETTA, Ga., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today the appointment of Tony Gibney as Chair of its Board of Directors, effective November 1, 2024. Mr. Gibney, who joined Clearside’s Board as an independent director in April 2024, succeeds Clay...Read more


Actinium Pharmaceuticals Appoints Accomplished Biopharma Industry Executive June Almenoff, M.D., Ph.D. to its Board of Directors

November 4
Last Trade: 1.80 -0.12 -6.25

Dr. Almenoff brings more than 25 years of drug development and leadership experience to the Actinium Board of Directors   Dr. Almenoff to join Actinium's Nominating and Corporate Governance Committee NEW YORK, Nov. 4, 2024 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a leader in the development of Antibody Radiation Conjugates (ARCs) and other targeted radiotherapies, today...Read more


Coya Therapeutics Announces Arun Swaminathan, Ph.D. Assumes New Role as Chief Executive Officer

November 1
Last Trade: 7.25 0.04 0.55

Company underscores potential benefits of low-dose interleukin-2 in Investigator-Initiated Phase 2 Alzheimer’s disease trial as presented at the recent CTAD Conference HOUSTON / Nov 01, 2024 / Business Wire / Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces that, as previously disclosed, Arun...Read more


MiNK Therapeutics Announces Appointment of Dr. Robert Kadlec to Board of Directors

October 31
Last Trade: 0.78 0.03 3.99

NEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE) -- MiNK Therapeutics (MiNK, NASDAQ: INKT), a clinical-stage company pioneering the development of allogeneic off-the-shelf, invariant natural killer T (iNKT) cell therapies, today announced the appointment of Dr. Robert Kadlec to its Board of Directors. Dr. Kadlec brings unparalleled expertise in biodefense, pandemic preparedness, and public health strategy, positioning MiNK to accelerate its...Read more


CONMED Announces Leadership Succession

October 30
Last Trade: 74.77 1.34 1.82

LARGO, Fla. / Oct 30, 2024 / Business Wire / CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman will retire as President and Chief Executive Officer (CEO) of the Company, effective January 1, 2025. Patrick Beyer, current Chief Operating Officer (COO) of CONMED, will succeed Mr. Hartman as President and CEO and will also be appointed as a member of the Company’s board, effective the same date. As part of the transition,...Read more


MacroGenics Announces Leadership Transition

October 30
Last Trade: 4.10 -0.25 -5.75

Scott Koenig, M.D., Ph.D., to step down as President and CEO Board to initiate search process to identify new CEO ROCKVILLE, MD, Oct. 30, 2024 (GLOBE NEWSWIRE) --  MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today announced that Scott Koenig, M.D., Ph.D., intends to...Read more


Carisma Therapeutics Announces Changes to its Board of Directors

October 30
Last Trade: 1.00 -0.02 -1.49

Appointment of Sohanya Cheng Resignation of Michael Torok PHILADELPHIA, Oct. 30, 2024 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced the appointment of Sohanya Cheng, MBA to the Company's Board of Directors, effective October 31, 2024. Additionally, Michael...Read more


Biogen Appoints Daniel Quirk, MD, as Chief Medical Officer

October 29
Last Trade: 168.28 -4.76 -2.75

CAMBRIDGE, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) has appointed Daniel Quirk, M.D., M.P.H., M.B.A. as Chief Medical Officer and Head of Medical Affairs, effective October 28, 2024. Dr. Quirk will report to Priya Singhal, M.D., M.P.H., Head of Development at Biogen. “At Biogen, scientific and medical leadership is the foundation for everything we do, and this is why we believe Dan will be a perfect fit to lead...Read more


23andMe Appoints Three New Independent Directors to Board

October 29
Last Trade: 4.71 0.23 5.13

SUNNYVALE, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (the “Company” or “23andMe”), a leading human genetics and preventive health company, today announced the appointments of Andre Fernandez, Jim Frankola, and Mark Jensen, three accomplished and experienced executives, as independent members of the Company’s Board of Directors (the “Board”), effective on October 28, 2024. Each of Mr. Fernandez, Mr....Read more


Skye Bioscience Names Independent Director Paul Grayson as Chairman of the Board

October 29
Last Trade: 5.39 -0.32 -5.60

SAN DIEGO, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for metabolic health, today announced the Board has appointed independent director Paul Grayson as Skye’s new Chairman of the Board, effective October 25, 2024. Mr. Grayson currently serves as a member of Skye’s Audit, Compensation and Nominating and Corporate...Read more


Sylvia Hermina Joins Aditxt’s Board of Directors, Elevating Leadership with Broader Perspectives

October 29
Last Trade: 0.37 0.01 3.42

MOUNTAIN VIEW, Calif. / Oct 29, 2024 / Business Wire / Aditxt, Inc. (“Aditxt” or the “Company”) (NASDAQ: ADTX), a social innovation platform dedicated to accelerating promising health innovations, today announced the appointment of Sylvia Hermina to its Board of Directors. With over 20 years of experience advising public companies on corporate governance, mergers and acquisitions, and shareholder relations, Ms. Hermina brings a wealth of...Read more


Ronald E. Bruehlman Joins GoodRx Board of Directors

October 28
Last Trade: 4.70 -0.19 -3.89

IQVIA CFO brings 39 years of healthcare and finance expertise to GoodRx SANTA MONICA, Calif. / Oct 28, 2024 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced the election of Ronald E. Bruehlman to its Board of Directors, effective November 8, 2024. Mr. Bruehlman brings to GoodRx 39 years of finance experience in...Read more


Electromed Appoints Peter Horwich, Vice President, Marketing

October 28
Last Trade: 26.44 0.95 3.73

Key hire will drive the Company’s market development and therapy adoption initiatives NEW PRAGUE, Minn. / Oct 28, 2024 / Business Wire / Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced the appointment of Peter Horwich as Vice President, Marketing. Mr. Horwich, an accomplished marketing veteran, brings over 20 years of experience in driving commercial growth...Read more


Fennec Pharmaceuticals Strengthens Executive Leadership Team with Three Key Appointments to Accelerate the Company’s Next Stage of Growth

October 28
Last Trade: 4.23 -0.06 -1.40

Pierre S. Sayad, PhD, M.S., Appointed Chief Medical Officer  Terry Evans Appointed Chief Commercial Officer  Christiana Cioffi, MBA, Appointed Chief Strategy Officer  RESEARCH TRIANGLE PARK, N.C., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that it has strengthened its executive leadership team with the...Read more


OS Therapies Appoints Two Bio-Pharmaceutical Industry Veterans to the Board of Directors

October 28
Last Trade: 2.63 -0.22 -7.72

Concurrently, the Company accepted the resignations of Dr. Colin Goddard and Mr. Joacim Borg NEW YORK / Oct 28, 2024 / Business Wire / OS Therapies (NYSE-A: OSTX) (“OS Therapies” or “the Company”), a clinical-stage immunotherapy and Antibody Drug Conjugate biopharmaceutical company, today announced the appointments of Avril McKean Dieser, MA, JD and Olivier R. Jarry, MS, MBA as independent members of the Company’s Board of Directors....Read more


Integer: Payman Khales to assume the role of Integer Chief Operating Officer and Andrew Senn to become President, Cardio & Vascular in the first quarter of 2025

October 24
Last Trade: 136.89 0.13 0.10

PLANO, Texas, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization (CDMO), today announced that Payman Khales will assume the newly created role of Chief Operating Officer during the first quarter of 2025. Andrew Senn will take Mr. Khales’ place as the President, Cardio & Vascular at the same time. Mr. Khales joined the Company in...Read more


Roberto A. Mignone Joins Guardant Health Board of Directors

October 24
Last Trade: 29.73 1.12 3.91

PALO ALTO, Calif. / Oct 24, 2024 / Business Wire / Guardant Health, Inc. (Nasdaq: GH), a pioneer in precision oncology, today announced the appointment of Roberto A. Mignone to its board of directors, effective immediately. Mr. Mignone is the Founder and Managing Partner of Bridger Management LLC, an investment management firm founded in 2000 and specializing in long-term equity strategies. “We are fortunate to welcome Roberto Mignone to...Read more


Humana Elects Gordon Smith to Board of Directors

October 23
Last Trade: 280.06 -8.06 -2.80

LOUISVILLE, Ky. / Oct 23, 2024 / Business Wire / Humana Inc. (NYSE: HUM) announced today that Gordon Smith has been elected as a member of the Company’s Board of Directors. Smith serves as an Operating Advisor of Clayton, Dubilier & Rice LLC (CD&R) Funds, a leading private investment firm. He was previously Co-President and Co-Chief Operating Officer of JPMorgan Chase & Co. (JPMorgan), where he was a member of the firm’s...Read more


Disc Medicine Appoints Seasoned Industry Executive Rahul Kaushik, Ph.D. as Chief Technical Officer

October 23
Last Trade: 63.26 -1.74 -2.68

WATERTOWN, Mass., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced the appointment of Rahul Rajan Kaushik, Ph.D. as the company’s Chief Technical Officer. Dr. Kaushik is an experienced biotech executive with...Read more


Ensign Announces Appointment of Mark Parkinson to the Board of Directors

October 21
Last Trade: 149.11 0.96 0.65

SAN JUAN CAPISTRANO, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG or the “Company”), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that the Board of Directors (the “Board”) appointed Mark...Read more


TruBridge Elects Amy O’Keefe to the Company’s Board of Directors

October 21
Last Trade: 15.63 2.08 15.35

New Director Brings Deep Financial and Operational Expertise MOBILE, Ala. / Oct 21, 2024 / Business Wire / TruBridge, Inc. (“TruBridge” or the “Company”) (NASDAQ:TBRG), a healthcare solutions company, today announced the election of Amy O’Keefe to its Board of Directors (the “Board”), effective October 18, 2024. O’Keefe currently serves as Chief Financial Officer of Avaya, a contact center and communications solutions provider backed...Read more


CVS Health Appoints David Joyner President and Chief Executive Officer

October 18
Last Trade: 54.03 -1.51 -2.72

Roger Farah Named Executive Chairman of the Board Company provides preliminary guidance for third quarter 2024 GAAP diluted Earnings per Share (EPS) of $0.03 to $0.08 and Adjusted EPS of $1.05 to $1.10 WOONSOCKET, R.I., Oct. 18, 2024 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced that David Joyner was appointed President and Chief Executive Officer, effective October 17, replacing Karen Lynch, who stepped down from her...Read more


Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors

October 18
Last Trade: 160.85 -1.56 -0.96

Mr. Scannell and Ms. Lane will Add Valuable Medical Technology, Finance and Corporate Governance Experience to Expanded Eight-Member Board IRVINE, Calif. / Oct 18, 2024 / Business Wire / Masimo Corporation (Nasdaq: MASI), a leading global medical innovator, today announced the appointments of Timothy J. Scannell and Wendy E. Lane to the Company’s Board of Directors (the “Board”), effective immediately. Following these appointments, the...Read more


American Shared Hospital Services Announces Key Management Appointments

October 18
Last Trade: 3.21 -0.02 -0.62

Hires Gary Delanois, Seasoned Radiation Oncology Services Executive, as Chief Operating Officer Promotes Ranjit Pradhan to Senior Vice President of Sales and Marketing SAN FRANCISCO, Oct. 18, 2024 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy cancer treatment systems and...Read more


DaVita Appoints Jessica Hergenreter as Chief People Officer

October 17
Last Trade: 158.04 8.38 5.60

DENVER, Oct. 17, 2024 /PRNewswire/ -- DaVita, a leading provider of kidney care services, today announced Jessica (Jess) Hergenreter as its new chief people officer (CPO). In this position, Hergenreter will oversee DaVita's People Services team, leading initiatives to engage and uplift DaVita's more than 70,000 teammates (employees) worldwide. Earlier this year, DaVita was named as a Top Workplace by USA Today and one of...Read more


AdaptHealth Appoints Diana Nole to Board of Directors

October 17
Last Trade: 10.69 0.60 5.95

PLYMOUTH MEETING, Pa. / Oct 17, 2024 / Business Wire / AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, today announced the appointment of Diana Nole to the Board of Directors, effective October 16, 2024. “We are thrilled to welcome Diana to the AdaptHealth Board of...Read more


HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization

October 17
Last Trade: 2.36 -0.21 -8.17

Industry leader brings extensive experience in developing go-to-market strategies for breakthrough products and delivering growth Founder and current CEO Branislav Vajdic named President to focus on advancing the Company’s groundbreaking vector-based technology for heart health, including AI applications SANTA CLARA, Calif. / Oct 17, 2024 / Business Wire / HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on...Read more


Tim Buckley Elected to Pfizer’s Board of Directors

October 15
Last Trade: 26.19 -0.53 -1.98

NEW YORK / Oct 15, 2024 / Business Wire / Pfizer Inc. (NYSE: PFE) today announced the election of Mortimer (“Tim”) J. Buckley to its Board of Directors, effective immediately, following a lengthy and comprehensive search that began in May 2024. Mr. Buckley, age 55, was also appointed to and will join the Governance and Sustainability Committee and the Audit Committee of Pfizer’s Board. Following the appointment of Mr. Buckley, the Board...Read more


C4 Therapeutics Appoints Paige Mahaney, Ph.D., as Chief Scientific Officer and Announces Retirement of Stewart Fisher, Ph.D.

October 15
Last Trade: 5.51 -0.55 -9.08

Mahaney Brings More Than 25 Years of Pharmaceutical and Biotech Experience Overseeing Drug Discovery and Expansion of Leading Discovery and Clinical Portfolios Fisher Will Serve as Senior Scientific Advisor Until December 31, 2024 WATERTOWN, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today...Read more


The Joint Corp. Appoints Sanjiv Razdan President and Chief Executive Officer

October 14
Last Trade: 11.75 0.14 1.21

Seasoned Franchise Executive to also Join the Company’s Board of Directors SCOTTSDALE, Ariz., Oct. 14, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT) (“The Joint or “the Company”), the nation’s largest franchisor of chiropractic care through The Joint Chiropractic® network, welcomes Sanjiv Razdan as its President and Chief Executive Officer effective today. Razdan will also serve as a member of the company’s Board of...Read more


Innate Pharma Appoints Jonathan Dickinson as New Chief Executive Officer and Chairman of the Executive Board

October 14
Last Trade: 1.90 0.06 3.19

Jonathan Dickinson joins Innate on November 1 and brings broad experience from leadership roles in biotech and big pharma Current interim CEO and co-founder Hervé Brailly will support the transition MARSEILLE, France / Oct 14, 2024 / Business Wire / Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that its supervisory Board has appointed Jonathan Dickinson as the...Read more


Sernova Announces Key New Executive Appointments

October 11
Last Trade: 0.23 -0.01 -4.17

Experienced leadership team positions company to advance Cell Pouch™ bio-hybrid organ programs. LONDON, Ontario; BOSTON, Massachusetts – TheNewswire – October 11, 2024 – Sernova Corp. (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company currently executing a phase 1/2 clinical study with its’ Cell Pouch™ bio-hybrid organ in type 1 diabetes is pleased to announce key new appointments to its executive...Read more


QuidelOrtho Announces New R&D Executive Leader

October 9
Last Trade: 41.14 -2.61 -5.97

Jonathan Siegrist appointed as EVP of R&D and CTO SAN DIEGO / Oct 09, 2024 / Business Wire / QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in innovative diagnostic solutions, is pleased to announce the appointment of Jonathan Siegrist, PhD, as its new Executive Vice President of Research and Development (R&D) and Chief Technology Officer (CTO), effective as of October 7, 2024. Siegrist brings a wealth of industry...Read more


Organon Canada Promotes Geneviève Gauthier as Executive Director, Corporate Affairs and Community Engagement and Appoints Jeffrey Malawski as Executive Director, Women's Health and Established Brands

October 8
Last Trade: 15.58 -0.46 -2.87

Organon Canada's operations are led by a diverse and highly capable team of equally represented men and women, offering a combination of relevant skills and experience, with a mission to deliver impactful medicines and solutions for a healthier every day for everyone, with a focus on women's health. KIRKLAND, QC, Oct. 8, 2024 /CNW/ - Organon Canada, a subsidiary of Organon (NYSE: OGN), a global healthcare company with a focus on...Read more


LivaNova Appoints Susan Podlogar as a New Director

October 8
Last Trade: 53.00 1.37 2.65

LONDON / Oct 08, 2024 / Business Wire / LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, announced its Board of Directors has appointed Susan Podlogar to the Board, effective today. Podlogar will serve on the Compensation and Human Capital Management Committee for the Board. “LivaNova’s Board of Directors is pleased to welcome Susan Podlogar,” said William Kozy, Chair of the Board. “Susan is a visionary leader with...Read more


Walgreens Appoints Jason Stenta as SVP and Chief Commercial Officer

October 7
Last Trade: 9.01 -0.06 -0.66

Stenta will lead B2B commercial growth strategy as the company strengthens its role as the first choice for community pharmacy and health services in the U.S. DEERFIELD, Ill. / Oct 07, 2024 / Business Wire / Walgreens, an integrated healthcare, pharmacy and retail leader serving millions of customers and patients every day, today announced the appointment of Jason Stenta as SVP and chief commercial officer. In this new role, Stenta...Read more


MultiPlan Announces Executive Leadership Changes

October 3
Last Trade: 8.72 0.22 2.59

Curren Katz Named Senior Vice President, Chief Data Science Officer Tara O’Neil Promoted to General Counsel; Scott Mays Promoted to SVP, Legal and Deputy General Counsel NEW YORK / Oct 03, 2024 / Business Wire / MultiPlan Corporation (“MultiPlan” or the “Company”) (NYSE: MPLN), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability to the U.S. healthcare...Read more


Iridex Appoints Patrick Mercer as Chief Executive Officer

October 3
Last Trade: 1.41 0.02 1.44

MOUNTAIN VIEW, Calif., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today announced the appointment of Patrick Mercer as the Company’s Chief Executive Officer and President effective October 1, 2024. Previously Mr. Mercer served as the...Read more


Abbas Hussain Joins Moderna's Board of Directors

October 2
Last Trade: 43.47 -3.36 -7.17

Hussain brings more than 35 years of commercial leadership and operating experience in healthcare, most recently serving as CEO of Vifor Pharma As former Global President of GSK, Pharmaceuticals and Vaccines, Hussain brings significant global vaccine commercialization experience in emerging and mature markets, along with significant Board of Directors expertise CAMBRIDGE, MA / ACCESSWIRE / October 2, 2024 / Moderna, Inc....Read more


COSCIENS Biopharma Announces Appointment of Pierre Labbé as Director

October 1
Last Trade: 3.00 0.00 0.00

TORONTO, ONTARIO, Oct. 01, 2024 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of cosmeceutical, nutraceutical and pharmaceutical products, announced the appointment of Pierre Labbé to its board of directors and as Chair of the Company’s Audit Committee, effective today, to fill the vacancy...Read more


Trevi Therapeutics Announces Appointment of James V. Cassella, Ph.D., as Chief Development Officer

September 30
Last Trade: 3.00 0.09 3.09

NEW HAVEN, Conn., Sept. 30, 2024 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in idiopathic pulmonary fibrosis (IPF) and refractory chronic cough (RCC), today announced the appointment of James V. Cassella, Ph.D., as Chief Development Officer (CDO).  "I am delighted to...Read more


Prothena Announces Leadership Team Updates

September 27
Last Trade: 17.36 -0.34 -1.92

Chad J. Swanson, Ph.D., appointed Chief Development Officer and will lead clinical development and medical functions Hideki Garren, MD, Ph.D., Chief Medical Officer, will pursue an opportunity at a large pharmaceutical company to lead a global product development division DUBLIN / Sep 27, 2024 / Business Wire / Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational...Read more


Global Oncology Innovator BeiGene Appoints Shalini Sharp to Board of Directors

September 26
Last Trade: 193.64 -11.83 -5.76

SAN MATEO, Calif. / Sep 26, 2024 / Business Wire / BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced the appointment of Shalini Sharp to its Board of Directors and as a member of the Board’s Audit Committee, effective September 27, 2024. “We are fortunate to welcome Shalini to the Board of Directors at this pivotal moment of growth,” said John V. Oyler, Co-Founder, Chairman and CEO of...Read more


Masimo Provides Leadership and Business Updates

September 25
Last Trade: 160.85 -1.56 -0.96

Appoints Michelle Brennan as Interim CEO Following Joe Kiani’s Decision to Resign Continues to Be Committed to Review of Strategic Alternatives for Consumer Businesses, With Assistance From Leading Financial and Legal Advisors Reaffirms Financial Guidance for Third Quarter 2024 IRVINE, Calif. / Sep 25, 2024 / Business Wire / Today the Board of Directors (the “Board”) of Masimo (Nasdaq: MASI) a leading global medical innovator,...Read more


Omnicell Appoints Nnamdi Njoku as Executive Vice President and Chief Operating Officer

September 25
Last Trade: 48.89 -1.25 -2.49

The Company taps business and operations executive with expertise that spans healthcare and med tech to help scale pharmacy automation and drive multi-year innovation and excellence FORT WORTH, Texas / Sep 25, 2024 / Business Wire / Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced that Nnamdi Njoku has been appointed Executive Vice President and...Read more


Catherine Owen Adams Succeeds Steve Davis as CEO of Acadia Pharmaceuticals

September 23
Last Trade: 17.93 0.27 1.53

Ms. Owen Adams brings over 25 years of pharmaceutical industry experience including senior commercial leadership roles with Bristol Myers Squibb and Johnson & Johnson SAN DIEGO / Sep 23, 2024 / Business Wire / Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that Catherine Owen Adams has succeeded Steve Davis as Chief Executive Officer (CEO) and joined the Acadia Board of Directors. “We are excited to welcome Catherine...Read more


OPKO Health’s ModeX Therapeutics Appoints Dr. Giovanni Abbadessa as Chief Medical Officer as Pipeline Advances into Clinical Development

September 23
Last Trade: 1.61 0.09 5.92

WESTON, Mass., Sept. 23, 2024 (GLOBE NEWSWIRE) -- ModeX Therapeutics Inc., an OPKO Health, Inc. (NASDAQ: OPK) company, today announced the appointment of Giovanni Abbadessa, M.D., Ph.D. as Chief Medical Officer, a newly created position. Dr. Abbadessa has over two decades of experience in drug development, including most recently as Vice President at Sanofi, where he provided executive leadership for advancing oncology assets. “Dr....Read more


Traws Pharma Appoints Luba Greenwood to Board of Directors

September 20
Last Trade: 5.90 0.00 0.00

Experienced Life Sciences Executive Brings Strategic Expertise to Support Traws’ Further Transformation and Growth Director James J Marino Also to Step Down from Traws Board After a Decade of Service NEWTOWN, Pa., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (Nasdaq: TRAW) (“Traws” or “the Company”), a clinical-stage biopharmaceutical company developing oral small molecule therapies for the treatment of respiratory viral...Read more


Immix Biopharma Announces Dr. Raymond Comenzo, Internationally Recognized AL Amyloidosis Expert, Director of the Myeloma and Amyloid Program at Tufts Medical Center, Joins Scientific Advisory Board

September 19
Last Trade: 1.72 -0.14 -7.53

Dr. Comenzo was the senior author of the landmark Andromeda trial results published in the New England Journal of Medicine in 2021, resulting in the first FDA-approved therapy for AL amyloidosis Dr. Comenzo was the lead author on the landmark 2012 publication of consensus guidelines, including response criteria, for conduct and reporting of clinical trials in AL Amyloidosis LOS ANGELES, CA, Sept. 19, 2024 (GLOBE NEWSWIRE) --...Read more


IDEAYA Biosciences Appoints Douglas B. Snyder as Senior Vice President, General Counsel

September 18
Last Trade: 30.98 -0.30 -0.96

Over 25 years of legal experience with leading healthcare organizations, including GW Pharmaceuticals, Actelion Pharmaceuticals, Eisai, GSK, and the U.S. FDA SOUTH SAN FRANCISCO, Calif., Sept. 18, 2024 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that Douglas B. Snyder, joined the company as...Read more


Kura Oncology Appoints Michael Vasconcelles, M.D., to Board of Directors

September 17
Last Trade: 18.57 0.89 5.03

SAN DIEGO, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced the appointment of Michael Vasconcelles, M.D., to its Board of Directors. Dr. Vasconcelles is an accomplished biopharmaceutical executive with more than 25 years of oncology drug development experience and industry...Read more


Vatroslav Mateljic Appointed General Manager of Takeda Canada

September 16
Last Trade: 13.54 -0.24 -1.74

Vatroslav Mateljic's innovative approach and commitment to transforming the lives of patients will strengthen Takeda's leadership position in the Canadian biopharmaceutical sector TORONTO, Sept. 16, 2024 /CNW/ - Takeda Canada Inc. ("Takeda Canada") is pleased to announce the appointment of Vatroslav (Vatro) Mateljic as its new General Manager to lead the Canadian operations of Japan's largest pharmaceutical...Read more


Sarepta Therapeutics Appoints Deirdre Connelly to its Board of Directors

September 16
Last Trade: 114.32 -7.29 -5.99

Veteran biopharmaceutical executive from GSK and Eli Lilly brings more than 30 years of experience to Sarepta’s Board CAMBRIDGE, Mass. / Sep 16, 2024 / Business Wire / Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced the appointment of Deirdre P. Connelly to its Board of Directors. Ms. Connelly is a well-regarded executive with more than 30 years of experience in the...Read more


Kyverna Therapeutics Announces Leadership Update

September 16
Last Trade: 5.22 -0.07 -1.32

Warner Biddle Appointed as Chief Executive Officer and to Board of Directors, Bringing Over 30 Years of Commercial, Product Planning and Franchise Leadership Experience, Including Successful Launches for CAR T Pioneer in Hematology Christi Shaw, Life Sciences Leader at Multiple Major Pharmaceutical and Biotech Companies and Across Therapeutic Areas, Appointed to Board of Directors Together Strengthen Leadership as Trailblazers of...Read more


DaVita Appoints David Maughan New Chief Operating Officer, Mike Staffieri Steps into Emeritus Role

September 13
Last Trade: 158.04 8.38 5.60

DENVER, Sept. 13, 2024 /PRNewswire/ -- DaVita, a leading provider of kidney care services, today announced that David Maughan will assume the role of chief operating officer. This appointment builds on Maughan's 18-year tenure at DaVita in a range of leadership roles. After a celebrated 11-year tenure as chief operating officer, Mike Staffieri will step into the role of chief operating officer emeritus. Both appointments are...Read more


Biogen Board Appoints Two New Independent Directors

September 12
Last Trade: 168.28 -4.76 -2.75

CAMBRIDGE, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- The Biogen Inc. (Nasdaq: BIIB) Board of Directors (the “Board”) today announced the appointments of two new independent directors, Lloyd B. Minor, M.D., effective October 1, 2024, and Sir Menelas (Mene) Pangalos, Ph.D., effective January 1, 2025. Dr. Minor is currently the Dean of the Stanford University School of Medicine and Vice President for Medical Affairs at Stanford University,...Read more


RadNet Announces the Appointment of Kees Wesdorp as President and Chief Executive Officer of RadNet’s Digital Health Division

September 12
Last Trade: 83.59 11.06 15.25

Former Chief Business Leader of Philips’ multi-billion-dollar Precision Diagnosis division and member of Philips’ Executive Committee End-to-end responsibility for Philip’s CT, MR, dXR, Ultrasound and Diagnostic Informatics (radiology software) businesses Proven track record of building and managing radiology software solutions, including significant experience with AI development and commercialization LOS ANGELES, Sept. 12, 2024...Read more


CareDx Appoints Keith Kennedy Chief Operating Officer and Jessica Meng Chief Commercial Officer

September 12
Last Trade: 23.32 -0.33 -1.40

CareDx Announces Addition of Operational and Commercial Expertise to Lead Key Strategic Initiatives Marica Grskovic Appointed Chief Strategy Officer to Lead Corporate Development BRISBANE, Calif. / Sep 12, 2024 / Business Wire / CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and...Read more


Rocket Pharmaceuticals Announces Appointment of Mikael Dolsten, M.D., Ph.D., to Board of Directors

September 10
Last Trade: 16.03 -1.42 -8.14

CRANBURY, N.J. / Sep 10, 2024 / Business Wire / Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced the appointment of Mikael Dolsten, M.D., Ph.D., as an independent director to its Board of Directors. Dr. Dolsten is an accomplished industry executive with extensive global...Read more


Jaguar Health Appoints Industry Veteran to Head Sales for Company’s Commercialized Oncology and HIV Products Including October 2024 Launch of Gelclair for Cancer Supportive Care

September 10
Last Trade: 1.09 0.15 15.58

FDA-approved Gelclair® is company's third commercialized prescription product Susan Krizancic appointed to role of National Sales Director at Jaguar family company Napo Pharmaceuticals SAN FRANCISCO, CA / ACCESSWIRE / September 10, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today announced that it has appointed biopharmaceutical industry veteran Susan Krizancic to the role of National Sales Director for Jaguar family...Read more


Eli Lilly appoints Lucas Montarce as executive vice president and chief financial officer

September 9
Last Trade: 818.86 -12.68 -1.52

INDIANAPOLIS, Sept. 9, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the appointment of Lucas Montarce as executive vice president and chief financial officer (CFO) and member of the company's Executive Committee, effective immediately. Since joining Lilly in 2001, Montarce has held a range of finance leadership roles, including serving as group vice president, corporate controller and chief financial...Read more


Baxter Appoints Jeffrey A. Craig to Its Board

September 9
Last Trade: 33.83 -0.81 -2.34

Addition of Mr. Craig complements current board expertise with deep financial, broad operational and public company board experience DEERFIELD, Ill. / Sep 09, 2024 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced it has appointed Jeffrey (Jay) A. Craig, former executive chair and chief executive officer (CEO) of Meritor Corporation, to its board of directors. Mr. Craig will serve on...Read more


Cassava Sciences Names Rick Barry as Chief Executive Officer

September 9
Last Trade: 26.38 -0.57 -2.12

AUSTIN, Texas, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on Alzheimer’s disease, today announced it has concluded its search for a Chief Executive Officer and that its Board of Directors has named Richard (Rick) Barry as CEO. Mr. Barry has served as a director of Cassava since June 2021. On July 17 of this year, the Board appointed him Executive...Read more


Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Business Officer

September 9
Last Trade: 1.70 -0.02 -1.16

BOSTON, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells, today announced the appointment of industry veteran Lucinda Warren as chief business officer (CBO). With an extensive background and proven expertise in strategic transactions, portfolio optimization and...Read more


Sign Up To Get Daily Life Science Stock News

Please review our Disclaimer and Privacy Policy before subscribing.

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

COPYRIGHT ©2023 HEALTH STOCKS HUB